Entera Bio Ltd.
ENTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001638097
No open-market purchases or sales by Entera Bio Ltd. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $19.0M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Entera Bio Ltd. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 14 | 14 | 0 |
| Shares | 5.11M | 5.67M | +554.5K (+10.8%) |
| Value | $30.6M | $26.7M | −$3.85M (−12.6%) |
New holders (5)
Institutions that held Entera Bio Ltd. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 683,007 | $3.22M | 0.01% |
| Bank of America Corp | 16,173 | $76.0K | 0.00% |
| Jane Street Group, LLC | 11,563 | $54.0K | 0.00% |
| Royal Bank of Canada | 1,894 | $9.00K | 0.00% |
| JPMorgan Chase & Co | 2 | $0 | 0.00% |
Sold out (5)
Institutions that held Entera Bio Ltd. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 66,733 | $399.0K |
| Verition Fund Management LLC | 30,523 | $183.0K |
| XTX Topco Ltd | 10,433 | $62.0K |
| Tower Research Capital LLC (TRC) | 9,008 | $54.0K |
| Cutler Group LP | 4,600 | $27.0K |